Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

November 30, 2023

Study Completion Date

January 31, 2027

Conditions
Giant Cell Arteritis
Interventions
DRUG

Corticosteroids for Systemic Use

"Corticosteroids tapering over 28 weeks:~J0 = 0,7 mg/kg S2 = 0,6 mg/kg S4 = 0,5 mg/kg S6 = 0,4 mg/kg S8 = 0,3 mg/kg S10 = 0,25 mg/kg S12 = 0,2 mg/kg S14 = 0,15 mg/kg S16 = 0,15 mg/kg S20 = 0,1 mg/kg S24 = 0,05 mg/kg S28 = 0 mg/kg~Corticosteroids tapering over 52 weeks:~J0 = 0,7 mg/kg S2 = 0,6 mg/kg S4 = 0,6 mg/kg S6 = 0,5 mg/kg S8 = 0,4 mg/kg S10 = 0,3 mg/kg S12 = 0,25 mg/kg S14 = 0,2 mg/kg S16 = 0,175 mg/kg S20 = 0,15 mg/kg S24 = 0,125 mg/kg S28 = 0,01 mg/kg S32 to S52: - 1mg per month"

All Listed Sponsors
collaborator

University Hospital, Lille

OTHER

collaborator

Amiens University Hospital

OTHER

collaborator

University Hospital, Rouen

OTHER

collaborator

University Hospital, Limoges

OTHER

collaborator

Central Hospital Saint Quentin

OTHER_GOV

collaborator

Central Hospital, Valenciennes

UNKNOWN

collaborator

Central Hospital, Lisieux

UNKNOWN

lead

University Hospital, Caen

OTHER